Provided by Tiger Trade Technology Pte. Ltd.

ORBUSNEICH

3.795
+0.0250.66%
Volume:50.00K
Turnover:188.77K
Market Cap:3.14B
PE:74.70
High:3.830
Open:3.800
Low:3.745
Close:3.770
52wk High:4.626
52wk Low:3.277
Shares:828.00M
HK Float Shares:827.97M
Volume Ratio:0.99
T/O Rate:0.01%
Dividend:0.20
Dividend Rate:5.27%
EPS(LYR):0.051
ROE:10.57%
ROA:6.24%
PB:0.96
PE(LYR):74.70
PS:2.05

Loading ...

OrbusNeich Delivers 18% Revenue Growth in 1H 2026, Lifts Gross Margin to 68.5% and Announces First-Ever Interim Dividend

Bulletin Express
·
Sep 07

OrbusNeich FY26 H1 Profit Attributable to Owners Rises 9% to Us$21.57 Million; Revenue Climbs 18.1% to Us$98.71 Million

Reuters
·
Sep 07

Orbusneich Medical Group Appoints Man Ying Chan as Chief Financial Officer

Reuters
·
Aug 17

ORBUSNEICH Appoints Liu Guizhen as Co-Chief Executive Officer, Effective August 2026

Stock News
·
Aug 17

OrbusNeich Medical Group Holdings Ltd - Wing Shing Chen Ceased to Act as Chief Financial Officer

THOMSON REUTERS
·
Aug 17

OrbusNeich Medical Group - Kwai Ching Denise Lau Appointed as Co-Chief Executive Officer

THOMSON REUTERS
·
Aug 17

OrbusNeich Medical Group - Appoints Man Ying Chan as Chief Financial Officer Effective August 17, 2026

THOMSON REUTERS
·
Aug 17

OrbusNeich Names Denise Lau Co-CEO Alongside David Chien

Reuters
·
Aug 17

OrbusNeich (SEHK:6929) Stock Catches Eyes As Margin Softening Meets Profit Growth

Simply Wall St.
·
Aug 14

OrbusNeich to Distribute HKD 0.08 Interim Dividend for FY 2026; Record Date Set for 24 September

Bulletin Express
·
Aug 14

OrbusNeich Medical Group Declares Interim Dividend of HKD 0.08 Per Share

Reuters
·
Aug 14

ORBUSNEICH reports 9.0% increase in net profit to $21.569 million for first half, with interim dividend of 8 HK cents

Stock News
·
Aug 13

Hong Kong's OrbusNeich H1 Revenue Rises

Reuters
·
Aug 13

OrbusNeich Medical Group Holdings H1 Revenue USD 98.7 Million

THOMSON REUTERS
·
Aug 13

OrbusNeich Medical Group - Interim Dividend of HK8 Cents Per Share

THOMSON REUTERS
·
Aug 13

OrbusNeich Keeps Share Base Steady at 827.97 Million in July; Confirms Public-Float Compliance

Bulletin Express
·
Aug 03

OrbusNeich Announces 13 Aug 2026 Board Meeting to Approve 1H 2026 Results and Potential Interim Dividend

Bulletin Express
·
Jul 31

OrbusNeich Medical Enrolls First Patient in Japan Trial of Coronary Balloon

MT Newswires Live
·
Jul 22

Orbusneich Targets End-2027 Completion of Japan Trial Enrollment for Proprietary Drug-coated Balloon

Reuters
·
Jul 22

OrbusNeich AGM Greenlights All Resolutions; HK 0.12 Final Dividend Set for 26 June 2026

Bulletin Express
·
Jun 08